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 Abstract
In this article, we report the number of cyclin B1 proteins tagged with enhanced green
fluorescent protein (eGFP) in fixed U-2 OS cells across the cell cycle. We use a quanti-
tative analysis of epifluorescence to determine the number of eGFP molecules in a
nondestructive way, and integrated over the cell we find 104 to 105 molecules. Based
on the measured number of eGFP tagged cyclin B1 proteins, knowledge of cyclin B1
dynamics through the cell cycle, and the cell morphology, we identify the stages of cells
in the cell cycle. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC. on behalf
of International Society for Advancement of Cytometry.
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OPTICAL microscopy techniques (1–3) are of fundamental importance to advance
our understanding of biological systems. Tools such as phase contrast, differential
interference contrast (DIC), and fluorescence microscopy are in widespread use in
bioimaging applications. While not chemically specific, quantitative phase contrast
(4–7) and DIC (8,9) can be used, apart from structural investigations, to quantita-
tively determine dry mass distribution in cell biology studies. On the other hand,
fluorescence based methods which are chemically specific due to the selectivity of
fluorophore binding sites can be applied in several ways, some of them offering
super-resolution down to the 10 nm range. In its simplest form, fluorescence micros-
copy is implemented in a widefield microscope with a lamp as the light source. To
obtain 3D sectioning, confocal laser scanning can be used, for example, to study the
cell cycle (10,11). Furthermore, two-photon laser scanning fluorescence (12–14) and
fluorescence lifetime imaging microscopy (15) have been used to study cellular pro-
cesses like protein interactions and metabolism (16). Despite the associated chal-
lenges of photobleaching and phototoxicity, fluorescence microscopy tools form the
basis of a large fraction of studies in biology (17), motivated by the high contrast
and the past development providing a tool-set of specific fluorophores.
Fluorescence was used in the past to quantify protein numbers and concentra-
tions in cells (18). Specifically, tagging with green fluorescent protein was calibrated
using rotavirus-derived virus-like particles (19), and different proteins were quanti-
fied in yeast using yellow fluorescent protein tagging (20), using immunoblotting for
calibration.
Cell division is a critical fundamental biological process essential to life as well
as organism growth and repair. During cell division, the genetic material (21) and
organelles (22,23) are replicated and distributed between the daughter cells. The cell
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cycle broadly comprises two stages (24), interphase and mito-
sis. During interphase, the cell undergoes growth and synthe-
sizes various biomolecules in preparation for mitosis. In the
mitotic stage of the cell cycle, distribution of the genetic mate-
rial and the organelles takes place, and thereafter, through
cytokinesis, the cell divides into two genetically identical
daughter cells. The progress of a cell through the cell cycle is
mediated by cyclin-dependent kinases (CDKs) and cyclins.
Binding of a specific cyclin to the CDK followed by phos-
phorylation of the CDK by a CDK activating kinase activates
the CDK (24,25). Various CDK-cyclin complexes are acti-
vated at different stages of the cell cycle, with CDK 1-cyclin B
driving the cell from the synthesis (S) phase of interphase to
the mitotic (M) phase. In cancer cells, the CDK–cyclin con-
trol of the cell cycle is rendered dysfunctional. Therefore, by
studying cyclins and CDKs or CDK-cyclin complexes, the cell
cycle of cancers can be probed from a biochemical and cell
biology point of view. Moreover, CDKs are also obvious tar-
gets of various anticancer drugs (26,27). Previously, flow cyto-
metry readouts of fluorophores targeting various parts of the
cell were studied in correlation with fluorescence microscopy
images to reveal the specificity of a new monoclonal antibody,
H3P mAb (28). In this extensive study, in addition to H3P
mAb, conventional fluorophores such as DAPI, propidium
iodide for DNA, and fluorescein for cyclins A and B1 were
used to conclude that the developed antibody is highly spe-
cific to histone H3 phosphorylated at Ser-10. The quantitative
results were drawn from flow cytometry while microscopy
was used to correlate the morphology and origin of the fluo-
rescence intensities within the cells.
In this article, we investigate cells expressing cyclin B1
genetically labeled with eGFP, and quantify the fluorescence
imaging to determine the number of these molecules in the
cell across the cell cycle. Notably, we use the known absorp-
tion cross section of eGFP to calibrate the number of mole-
cules in a calibration sample, and then determine the
fluorescence per molecule on this sample, to calibrate the
fluorescence imaging. The quantification method demon-
strated in this article can be applied to similar biomedically
relevant studies, for example, to measure the concentrations
of fluorophore target molecules or to reveal pharmacodynam-
ics of various autofluorescent drugs.
MATERIALS AND METHODS
Sample Preparation
Human osteosarcoma cells [U-2 OS] (GFP G2M P2B2) trans-
fected with a G2M Cell Cycle Phase Marker (GE Healthcare,
UK) were cultured (29) under standard tissue culture
(TC) conditions. The cells were seeded on #1 coverslips
placed into a single well of a multiwell plate and allowed to
adhere, spread, and proliferate for 24 h, in complete TC
media comprising McCoys media, 10% fetal bovine serum
(FBS), penicillin/streptomycin, glutamine, and G418. To pre-
pare 400 ml medium, we used 348 ml McCoys 5A media
(Sigma M8403, UK), 40 ml FBS, 4 ml solution of 100×
Penicillin/Streptomycin (Sigma P0781, UK), 4 ml 100×
L-Glutamine (Sigma C5914, UK), and 4 ml G418 (50 mg/ml
in water) (Sigma G8168, UK). The cells were washed with
PBS and subsequently fixed for 30 min in BD-Cytofix
(BD Biosciences, San Jose, CA), a mild fixative agent that pre-
vents the denaturation of eGFP. Following preparation, the
well plates were covered and kept refrigerated at 4C until
imaging. To mount the cells for imaging, approximately 13 μl
PBS was pipetted into a well created by the 13 mm diameter
opening of a 0.12 mm thick adhesive imaging spacer (Grace
Biolabs Secure Seal, Bend, Oregon) on a microscope slide.
The coverslip was then inverted over the medium-filled well
on the slide and sealed, ready to be imaged. Since cyclin B is
active in the mitotic stage of the cell cycle, fluorescence imag-
ing of eGFP-B1 transfected cells enables accurate discrimina-
tion of the mitotic cells from interphase or quiescent cells on
the coverslip. For quantitative reference, a calibration sample
was prepared with approximately 10 μl of a 40 μM eGFP
solution produced recombinantly, as described previously
(30,31). The eGFP solution was pipetted to fill the 9 mm
diameter opening of a 0.12 mm thick imaging spacer (Grace
Biolabs Secure Seal, Bend, Oregon). A #1 coverslip was
inverted over the spacer, creating a sealed well of eGFP.
Setup
The epifluorescence images used in this article were acquired
on an inverted microscope (Nikon Ti-U) equipped with
brightfield, DIC, and epifluorescence. We use a dry objective
(Nikon MRD00205) of 0.75 numerical aperture (NA) and
20× magnification. For epifluorescence imaging, we used as
the source of excitation a broadband metal-halide lamp
(Prior Lumen 200). The emission of the lamp was filtered
using a filter cube (Semrock GFP-A-Basic-NTE, comprising
an exciter (FF01-469/35-25), an emitter (FF01-525/39-25),
and a dichroic (FF497-Di01-25x36)). The cells were imaged
using a monochrome CCD camera (Hamamatsu Orca) with
1,344 × 1,024 pixels of 6.45 μm size, 8 electrons (e) read noise
and 18 ke full well capacity.
The absorption spectrum of the calibration sample
was measured on a spectrometer (USB2000-FLG Ocean
Optics) with an operation range of 380–1,050 nm. The
light source in this setup was a lamp (HL-2000-FHSA
Ocean Optics).
RESULTS
To calibrate the fluorescence microscopy, we first measured
the absorbance, A of the calibration sample using the relation
A= − log10
S−D
R−D
 
, ð1Þ
where S is the transmission intensity spectrum of the calibra-
tion sample (eGFP), R is the transmission intensity spectrum
of a reference sample prepared equal to the calibration sample
but not containing eGFP, and D is the dark spectrum (taken
with the lamp switched off). The resulting absorbance
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spectrum of eGFP, with a maximum value 3.46% at a wave-
length of λ = 488 nm is shown in Figure 1 as black line.
Using Lambert–Beer’s law, A = εCl, where ε is the molar
extinction coefficient and l is the pathlength traveled by the
incident light through the solution, the molar concentration
C of eGFP in the solution can be determined. For eGFP at
λ = 488 nm, we have ε = 53,000 M−1 cm−1 (32), and the pat-
hlength l is 120.8 μm, measured using the microscope focus-
ing stage while imaging with a water immersion objective
(Nikon 60× 1.27NA, MRD70650). Due to the matching
immersion and medium index, spherical errors are avoided
and the focus motion in the sample is equal to the motion of
the objective.
Using these values in Lambert–Beer’s law, the concentra-
tion of eGFP in the solution is determined to be 54 ± 5 μM,
considering 5% relative error in absorbance, 8% relative error
(32) in ε, and 0.5% relative error in the pathlength. The num-
ber of eGFP molecules per area in the calibration sample, n,
is then calculated using the relation n = CNAl, where NA is
Avogadro’s number. The error in n is dominated by the error
in C, resulting in n = (3.9 ± 0.4) × 1014/cm2. These values
were then used to quantify the eGFP in cells. The epi-
fluorescence images were analyzed in ImageJ (NIH) to calcu-
late the sum of intensities, Ic of pixels enclosed within a
contour defining the boundary of the cell. These intensities
were then normalized with the fluorescence of the eGFP sam-
ple imaged under otherwise identical conditions to calculate
the number of eGFP molecules in the cells given by
Nc =
nIcτpA0
Ipτc
, ð2Þ
where τp = 0.6 ms and τc = 5 s (unless otherwise specified)
are the exposure times used to acquire the images of
the eGFP sample and the cells, respectively. Ip = 2,385 is the
mean pixel intensity in counts measured over an area of the
image of the pure eGFP sample and A0 is the camera pixel
area at the sample, equal to 0.104 μm2 for the 20× 0.75NA
objective used for the fluorescence imaging. The fluorescence
emission of this sample showed a systematic variation of 6%
standard deviation from its mean value across the field of
view of the dry objective used for cell imaging. This variation
is much smaller than the variations between cells and thus
does not significantly affect the analysis. The illuminated size
on the sample has about 1mm diameter. The blurring of the
edges of the field due to the depth of the sample is given by
120 μm× 0.75/1.33 = 68 μm, using the refractive index of
water of 1.33, and is not affecting the center 0.5mm of the
field analyzed in this article.
The detection efficiency ED = ToECCDFΩ = 3.1% of the
setup is determined by the transmission of the optics
To = 0.6, the camera quantum efficiency ECCD = 0.6, and
the collected fraction of the full solid angle given by
FΩ = Ω/(4π) = 8.7% for 0.75NA in water of refractive index
1.33. The illumination intensity at the sample is estimated
starting with the number of eGFP per camera pixel
Np = nA0 = 4.1 × 10
5. The photon emission rate per eGFP
is then given by νe =Γ Ip=ðτpNpEDÞ= 1,500Hz, using the
camera gain, Γ = 4.45 electrons/count. The photon absorption
rate is then given by νa = νe/EeGFP = 2,500 Hz using the quan-
tum efficiency EeGFP = 0.6 of eGFP (31). The eGFP absorption
cross section at λ = 488 nm is then calculated as σ = log
(10)ε/NA = 2.03× 10
−16 cm2, and the excitation intensity as
I = νahc/(λσ) = 5.0 W/cm
2.
After this calibration, we determined the spatially
resolved eGFP densities across a large number of cells cover-
ing different stages across the cell cycle, and determined Nc
integrating over the cell area. Background corrected images
were used, where the background was determined as the
mean pixel value over an area (70 × 70 pixels) of the cover-
slip adjacent to but outside the cell. This was subtracted from
each pixel of the cell image before calculating the number of
molecules. In Figure 2, Nc is plotted against cell cycle stage
identifier, showing a distribution in the range of 104 to 105
eGFP-cyclin B1 molecules per cell. The stage identifier is a
number sorting the cells along the cell cycle, assigned using
their morphology and their eGFP-cyclin B1 expression. For
this assignment, we recall that cyclin B1 is produced during
the S phase, in the rough endoplasmic reticulum. The meta-
phase promoting factor, which is cyclin B1 with CDK1, is
localized in the cytosol during interphase (G2) and gets trans-
ported to the nucleus before the disintegration of the nuclear
envelope in prophase, marking the onset of mitosis (33). After
the chromosome alignment on the metaphasic plate (34),
cyclin B1 degradation begins. In the samples studied, the
eGFP emission was accordingly found to be stronger either in
the cytoplasmic or in the nuclear region of the cell, depending
on the cell cycle stage.
In addition to the cell cycle stage dependent variation,
the number of cyclin B1 molecules at each stage of the cell
cycle varies also across the individuals of the cell population.
Figure 1. Absorbance spectrum of the calibration sample (black
line). For comparison, the dichroic, exciter, and emitter
transmission spectra specified by the manufacturer are shown in
blue, red, and green, respectively. [Color figure can be viewed at
wileyonlinelibrary.com]
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Smith et al. have reported a typical relative decrease of
eGFP-cyclin B1 expression of approximately 35% in U-2 OS
cells in metaphase over two consecutive cell cycles (35). This
inherent variation in cyclin B1 expression between cells
makes it difficult to sort cells in broadly classified substages of
interphase using the eGFP expression only.
For the analysis presented in this section, 29 epi-
fluorescence images showing 39 fixed U-2 OS cells were
selected. The selection was made to exclude cells on top of
each other, and included those exhibiting different shapes
and fluorescence intensities to ensure a broad population
spread comprising individuals in various stages of the cell
cycle. For the images containing two cells, we assume the
cells to be in the same stage. The cell stage identifiers were
assigned to the epifluorescence images using the eGFP
localization according to Table 1, number of molecules
(calculated using Equation 2) and by identifying the mor-
phological features of the cells at various stages of the cell
cycle, considering the spatial distribution of eGFP in the
cells. The numbering of the cell cycle stage is aligned chro-
nologically along the cell cycle, starting with interphase. In
the following discussion, we refer to the cells and their
images using their stage identifier number. In this method,
we sorted the cells first into interphase and the substages of
mitosis by observing their morphology. Flat cells were des-
ignated as interphase cells while the cells showing a
spherical morphology were considered mitotic. Within
mitosis, the cell morphology changes from metaphase to
cytokinesis, which was taken into account. Finally, within
the identified stages, the cells were arranged in either
increasing or decreasing order of the number of eGFP mol-
ecules according to the expected trend relative to cells in
metaphase. In the leading and trailing regions of the curve
shown in Figure 2, we observe that the daughter cells which
appear attached to each other (cells 4–7, 9, and 11) with or
without apparent cytoplasmic division, are given lower
identifier numbers than cell 29 which appears to be in early
stages of cytokinesis. This was done due to the higher num-
ber of eGFP molecules in this set of cells compared to cell
29, relying on the knowledge that cyclin B1 levels reach a
maximum in metaphase following which they decline
Figure 2. Quantitative analysis of eGFP expression along the cell cycle (images of cells are placed next to the data points). Cells 3, 6,
14, 18, 24, and 29 were imaged using 1.5 s exposure time. The scale bar shown on the first cell is 10 μm and is valid for all images shown
in the plot. Data points indicated in red circles are the values over the cells, in some cases, over two cells. Data points represented by blue
stars correspond to the images which show two cells almost completely separated cytoplasmically for which the number of eGFP
molecules was evaluated across both the cells, and then divided by two. In these cases, the images of the cells have been placed near the
blue stars to indicate the half value to be considered in analysis. The numbers next to the images give the maximum area concentration
of the gray scale used (black [0] to white [maximum]), in units of molecules/μm2. [Color figure can be viewed at wileyonlinelibrary.com]
Table 1. Localization of cyclin B1-eGFP throughout the cell cycle
in fixed cells (33,34,36)
CELL CYCLE STAGE CYCLIN B1-EGFP LOCALIZATION
Interphase (S, G2) Cytosol, microtubules
Late G2 Cytosol, centrosomes
Prophase Nucleus
Prometaphase Spindles
Late metaphase onwards Progressive degradation
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(cyclin B1 expression is actually the net rate of production
of the protein, but the expression level refers to the number
of proteins, represented here by the fluorescence intensity
of the eGFP attached to the protein). While the number of
eGFP molecules in cell 14 is lower than that of cells 12 and
13, cell 14 is given a higher identifier number due to its
mitotic morphology. Such correlations were applied over
the entire set of cells imaged and the resulting plot given in
Figure 2 shows the variation of the number of cyclin B1
molecules via the number of eGFP molecules per cell, over
various cells fixed in different stages of the cell cycle. We
have included cells showing the weakest fluorescence,
which are in G1/S, to provide an upper limit for the
autofluorescence of the cells. The graph shows that the
eGFP number increases by an order of magnitude to about
105 molecules/cell as the cells approach mitosis, peaks at
metaphase and progressively declines thereafter until the
next cell cycle commences.
The maximum areal number density of eGFP molecules
given in the image scaling shown in Figure 2 is calculated as
Figure 3. Epifluorescence images of the cells shown in Figure 2 arranged in order of increasing stage identifier (indicated top left of each
image) from left to right in each stage of the cell cycle (top to bottom). The numbers on bottom left of the images are the detected
photoelectron rates from the cell in MHz. The scale bars shown are 10 μm.
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nmax = nImaxτp=ðIpτcÞ, where Imax is the maximum pixel value
within the cell area. The result of this analysis is an eGFP
expression during the cell cycle which is consistent with the
known behavior of cyclin B1 (see Table 1). Using a cell vol-
ume of 4,000 μm3 (37), the molar concentration of eGFP in
mitotic cells with 1.3× 105 eGFP molecules is 54 nM. High-
resolution images of the cells, of which thumbnails are given
adjacent to the data points in Figure 2, are shown in Figure 3
to display clearly the cell morphologies. The total number of
photoelectrons detected per second over each cell is also
given, calculated as Npe =ΓIc/τc. Previously, confocal fluores-
cence was used to measure cyclin B GFP expression by
mRNA injection in starfish oocytes (38). The endogenous
concentration was estimated to be 20 nM using the effect of
the expression on the germinal vesicle breakdown timing.
This is close to the concentration we have determined in our
analysis of U-2 OS cells.
In literature, a 1:1 correspondence between the num-
bers of eGFP and cyclin B1 molecules in U-2 OS cells has
been reported (39) using flow cytometry. Specifically, in G1
cells, 2,500 and in G2 cells, 7,000 molecules of eGFP-cyclin
B1 were calculated (39). It is expected that the number of
eGFP and cyclin B1 molecules will increase in the subse-
quent mitotic stages. In comparison to these values on live
cells, we obtain for fixed cells, molecule numbers of the
order of (0.9–5) × 104 in G1 and G2 and around 10
5 in the
mitotic stage of the cell cycle. The differences in the results
could be related to the variability in the cyclin B1 expression
across different cells in a population and over subsequent
cell cycles. Additionally, differences in the number of mole-
cules of cyclin B1 in HeLa cells depending on the counting
method used have been reported (40), where the results of
quantitative Western blotting of HeLa cells indicate cyclin
B1 molecule numbers/cell of a few 106, consistent with
another study (41). However, the results in these two publi-
cations are 2–3 orders of magnitude higher than those
reported by Arooz et al. (42). Since all three studies use
Western blotting, it is possible that these variations are due
to biological reasons or sample preparation methods as indi-
cated by Frisa et al. (40).
In contrast to Western blotting and flow cytometry
(which are also technically invasive and complex) the pres-
ented method using epifluorescence imaging is a relatively
fast, direct, and simple technique which facilitates eGFP-
cyclin B1 concentration determination, requiring only conve-
ntional and readily available optical microscopy components.
Our results are in between those in literature (39–42). We
note that our method is sensitive to the following issues iden-
tified previously (18): (i) Autofluorescence—which we have
estimated by analyzing the cells of weakest fluorescence. They
show equivalent emission of around 104 eGFP per cell, and
around 10 eGFP/μm2. This is one order of magnitude below
the highest levels seen during mitosis, providing an upper
limit for the autofluorescence. (ii) Fluorescent proteins need
to fold to their correct conformation for both maturation and
fluorescence. eGFP has been engineered to fold efficiently in
cells and is one of the most broadly used of all the fluorescent
proteins. Refolding studies suggest that 77% of the protein
can fold back into its active conformation (43). This fraction
may contribute to the observation that the number of cyclin
B1 molecules being 30% higher than the measured folded
eGFP molecules. (iii) eGFP interactions at high concentra-
tions changing the quantum yield—this is unlikely consider-
ing the low concentrations. Specifically, for the observed
105 eGFP per mitotic cell, assuming 4,000 μm3 cell volume,
corresponds to an average distance of 342 nm. Interactions
are only expected for distances below 10 nm. (iv) Fluorescent
protein association. eGFP is predominantly monomeric but
does have a weak tendency to dimerize (44), which is not
normally a problem for most imaging applications. While
dimerization is not expected to change the fluorescence prop-
erties significantly, recent work has shown that in certain cir-
cumstances the molar absorbance coefficient can be enhanced
on more permanent dimerization of a related GFP (45). How-
ever, this may only become a problem if the fusion partner
(cyclin B1 in this case) dimerizes and brings the eGFP mole-
cules close together in space so promote their dimerization.
This is likely to be rare and can be overcome by changing the
termini and/or linker sequence when fusing to eGFP.
CONCLUSIONS
We have demonstrated a simple method to quantify the
number of fluorophores in cells using standard epi-
fluorescence microscopy, and applied it to cyclin B1 expres-
sion during the cell cycle of fixed cells. We find expression
levels of around 104 in G1/S phase, and around 10
5 during
mitosis. The method is applicable also to live cell studies,
and we believe that similar studies on live cells are likely to
reveal biomedically relevant information by imaging and
quantifying directly the spatially resolved expression levels
of proteins.
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